Original Research

Assessment of efficacy, safety, and tolerability of 4-n-butylresorcinol 0.3% cream: an Indian multicentric study on melasma

Madan Mohan NT, Gowda A, Jaiswal AK, Sharath Kumar BC, Shilpashree P, Gangaboraiah B, Shamanna M

Clinical, Cosmetic and Investigational Dermatology 2016, 9:21-27

Published Date: 21 January 2016